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Summary: The binding of [125I]insulin to erythrocytes, glucose and insulin were determined before and l, 7 and
35 days after ingestion of 2 X 60 mg 16-methyleneprednisolone. None of two groups of volunteers (7 males, 4 females)
showed clear alterations of the insulin binding parameters (Ka and R0), or of the fasting Cortisol, glucose and insulin
concentrations.
These results exclude the possibility that the diabetogenic effect of glucocbrticoids is accompanied by an alteration
of the insulin receptor characteristics of erythrocytes.
Insulinbindung an Erythrocyten nach akuter Gabe von 16-Methylen-prednisolon
Zusammenfassung: Die Bindung von [125I]Insulin an Erythrocyten sowie die Konzentrationen von Cortisol, Glucose
und Insulin im Plasma wurden vor und l, 7 und 35 Tage nach Gabe von 2 X 60 mg 16-Methylen-prednisolon ermit-
telt. In keinem Falle (7 Männer, 4 Frauen) konnten deutliche Änderungen der Insulin-Bindungsparameter sowie der
Nüchtern-Cortisol·, ^Glucpse- und -Insulin-Konzentrationen beobachtet werden.
Die vorliegenden Ergebnisse schließen aus, daß die diabetogene Wirkung von Glucocorticosteroiden an einer Ände-
rung der Characteristika der Insulin-Rezeptoren von Erythrocyten erkannt werden kann.
Introduction
Glucocorticoid admMstration is knöwn tö produce
insulin resistance (1) and it has been suggested that the
diabetogenic effect of cöfticosteroids njight be mediated,
at least in pärt, via changes in insulin receptors (2). Until
now quite different »results on the effect of glucocorticoids
on insulin binding häve been reported (2,3, 5,9). There-
„fpre insulin binding on erythrocytes «was studied in nor-
mal volünteers after an acute high-dose steroid treat-
ment which is currentiy being used clinically in man.
Materials and Methods
Subjects
Two groups of subjects were investigated:
(A) 7 healthy males and
(B) 4 healthy
Each of them received each 60 mg of 16-methyleneprednisolone
(Decortilen, Merck) at two süccessive days. Heparinized blood
samples were drawn by venipuncture in the fasting state before
steroid ingestion äs well äs 24 hours after the second dosage, 7
days later and after 5 weeks.
Insulin binding studies
Insulin binding was performed according to the procedure of
Gambhir (6) with slight modifications (4). Isolated erythrocytes
(3.5^-4.5 · 1012/1) were incubated with [125Ilinsulin
(0.05 nmol/1) and additionally with unlabeled insulin (0.09-
174 nmol/1) at 15 °Cfor 3 hours; nonspecific binding was deter-
mined in the ränge between 0.5 and 17.4 / of unlabeled
hormone and an average was subtracted from total binding to
give specific insulin binding.
Analytical procedures
Insulin (7) and Cortisol (Amersham/Buchler) were determined
radioimmunologically, glucose was measured by the glucose
oxidase method (Boehringer/Mannheim).
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Calculation proccdures
In view of our reccnt finding of a critical ligand concentration
(8), the analysis of binding data was performed on the initial
pari of the Scatchard plot up to a total ligand concentration of
about 2 nmol/1. Individual Scatchard plots were made for each
subject, and receptor affinity and concentration were calculated
from the initial points of the Scatchard plot by linear regression
methods. Statistical analyses were carried out using the Wücoxon
tcst for paired data. From the total binding data, the analytical,
the intra- and the interindividual variances were calculated.
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Results
After an acute glucocorticoid treatment no significant
changes of the erythrocyte Insulin receptor affinity and
concentration could be observed l, 7 and 35 days after
ingestion of the steroid in males (fig. l'and 2, tab. 1).
Endogenöus Cortisol tended to decrease one day after
steroid adininistration and to increase afterwards whereas
insulin seemed to be slightly eleväted after orie day
followed by a normalizätion, but nöne of the differences
were significant. Plasma gjücose levels, too, did not ^
exhibit significant changes (fig. 3). In females there were
slight differences in Ka between days 7 and 35 äs well
äs in R0 between days l and 35 and between days 7
and 35. But these differences could be calculated only
for p < 0.2 (fig. 2 and tab. 1). Plasma cortisol, insulin
and glucose cöncentrations did not change significantly
in females (fig. 3).
Tab. 1. Significance of differences in erythrocyte insulin recep-
tor affinity ( *)' and concentration (R0) before (0) arid
after (l, 7, 35 äays) ädministratiön of 16-methylene-
prednisolone calculated by Wücoxon's test for paired
data.
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Fig. 1. Specific insulin binding to human erythrocytes (4 · 1012/1)
before (A) äs well äs l day (o), 7 days (D) and 35 days ( )
after ädministratiön of 2 X 60 mg 16-methyleneprednisol-
one.
 ß(125IJinsulin binding (—) in dependence on the total
insulin concentration (nmol/1).
a = means of the data from 7 males
b = means of the data from 4 females
Insets: Scatchard plots derived from the corresponding
binding data; slopes of the straight lines (linear regression
up to 2 nmol/1) indicate receptor affinity; i^tercepts with
the abscissa indicate the maximal amount of insulin
bound.
Analysis of variances was performed for the lower (0.05-
2 nmol/1) and the higher (17.4-174 nmol/1) ranges of
total ligand concentrations separately. The analytical
variances were 4—10% CV för the lower ränge, 19—44%
CV for the higher ränge; the corresponding data for the
intraindividual variances were 12 -^21% and 37—56%,
and for the interindividual variances 45—47% and 58^
65%CV.
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Discussion
By employment of a modified Scatchard analysis (8),
the current results show no modulation of the erythro-
cyte Insulin receptor after 16-methyleneprednisolone
administration. This is in agreement with the results of
Fantus et al. (9) who did not find any alteration on
monocyte insulin receptors after prednisone ingestion.
In contrast, Yasuda et al. (5) reported a decrease of the
receptor affinity on erythrocytes and Beck-Nielsen et al.
(3) found an increase of the receptor concentration on
monocytes. These contradictary results can be partially
explained by the individual data handling of each in-
vestigator (4). There are slight differences of the experi-
mental procedures, like the size of the corticosteroid
doses and the time of blood withdrawal after steroid
ingestion. But these should influence the degree rather
than the quality of alterations of the receptor.
Receptor binding data were calculated from the terminal
part of the Scatchard plot. As can be seen by the analysis
of variances one would expect sufficient reliability of
the results only from data in the lower ränge of total
ligand concentrations, i.e. from the initial part of the
Scatchard plot. We demonstrated that the binding
Parameters Ka and R0 calculated from the initial part
of the Scatchard plot (up to total ligand concentrations
representing the half maximal Inhibition concentration
of the System) were nearly identical with those calcu-
lated by employment of a non-linear least squares
method (8). Therefore we focused our calculation on
the initial part of the Scatchard plot.
Our räsults exclude the possibility that the diabetogenic
effect of glucocorticosteroids is reflected in alterations
of the erythrocyte insulin receptor characteristics.
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Fig. 2. Affinity (Ka) and concentration (Ro) of the erythrocyte insulin receptors before (0) and after (l, 7, 35 days) administration
of 2 X 60 mg 16-methylenepre<lnisolone för 7 males (a) and for 4 females (b).
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Fig. 3. Plasma cortisol, insulin andglucose concentrations before (0) and after (l, 7, 35 days) administration of 2 X 60 mg 16-methyle-
neprednisolone for 7 males (a) and for 4 females (b).
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